These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 38149129)

  • 1. A Review of Incidence and Related Risk Factors in the Development of Hepatocellular Carcinoma.
    Lampimukhi M; Qassim T; Venu R; Pakhala N; Mylavarapu S; Perera T; Sathar BS; Nair A
    Cureus; 2023 Nov; 15(11):e49429. PubMed ID: 38149129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for hepatocellular carcinoma in India.
    Kar P
    J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S34-42. PubMed ID: 25755609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological and etiological variations in hepatocellular carcinoma.
    Sagnelli E; Macera M; Russo A; Coppola N; Sagnelli C
    Infection; 2020 Feb; 48(1):7-17. PubMed ID: 31347138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current epidemiology in hepatocellular carcinoma.
    Konyn P; Ahmed A; Kim D
    Expert Rev Gastroenterol Hepatol; 2021 Nov; 15(11):1295-1307. PubMed ID: 34624198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the Epidemiology of Hepatocellular Carcinoma in Asia.
    Liu Y; Liu L
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis.
    Tang A; Hallouch O; Chernyak V; Kamaya A; Sirlin CB
    Abdom Radiol (NY); 2018 Jan; 43(1):13-25. PubMed ID: 28647765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection.
    Wu HC; Jeng WJ; Pan MH; Hsieh YC; Lu SN; Chen CJ; Yang HI
    JHEP Rep; 2022 Feb; 4(2):100410. PubMed ID: 35079699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease: Universal or Selective?
    Plaz Torres MC; Bodini G; Furnari M; Marabotto E; Zentilin P; Strazzabosco M; Giannini EG
    Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32486355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Related Hepatocellular Carcinoma.
    Petruzziello A
    Open Virol J; 2018; 12():26-32. PubMed ID: 29541276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Historical Overview on the Role of Hepatitis B and C Viruses as Aetiological Factors for Hepatocellular Carcinoma.
    Stroffolini T; Stroffolini G
    Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma in Asia: Prevention strategy and planning.
    Ashtari S; Pourhoseingholi MA; Sharifian A; Zali MR
    World J Hepatol; 2015 Jun; 7(12):1708-17. PubMed ID: 26140091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide.
    Kim DY
    J Liver Cancer; 2024 Mar; 24(1):62-70. PubMed ID: 38523466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of Hepatocellular Carcinoma.
    McGlynn KA; Petrick JL; El-Serag HB
    Hepatology; 2021 Jan; 73 Suppl 1(Suppl 1):4-13. PubMed ID: 32319693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma in cirrhosis: incidence and risk factors.
    Fattovich G; Stroffolini T; Zagni I; Donato F
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S35-50. PubMed ID: 15508101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging trends in hepatocellular carcinoma: focus on diagnosis and therapeutics.
    Flores A; Marrero JA
    Clin Med Insights Oncol; 2014; 8():71-6. PubMed ID: 24899827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etiology of Hepatocellular Carcinoma: Special Focus on Fatty Liver Disease.
    Suresh D; Srinivas AN; Kumar DP
    Front Oncol; 2020; 10():601710. PubMed ID: 33330100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
    Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
    J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing epidemiology of hepatocellular carcinoma in Asia.
    Zhang CH; Cheng Y; Zhang S; Fan J; Gao Q
    Liver Int; 2022 Aug; 42(9):2029-2041. PubMed ID: 35319165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epidemiology and prevention of hepatocellular carcinoma.
    Monto A; Wright TL
    Semin Oncol; 2001 Oct; 28(5):441-9. PubMed ID: 11685737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma epidemiology.
    Bosetti C; Turati F; La Vecchia C
    Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):753-70. PubMed ID: 25260306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.